chrisvoncsefalvay/vaers-outcomes huggingface dataset:
every joint in my body ached; Initial information received on 30-Dec-2021 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp via social media.  This case involves patient of unknown demographics who reported every joint in his/her  body ached while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (strength, formulation, frequency, route, administration site, lot number and expiry date was unknown) for Flu vaccination.  On an unknown date the patient developed a non-serious event "every joint in my body ached" (arthralgia) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (every joint in my body ached).  At time of reporting, the outcome was Recovered / Resolved on an unknown date for the event every joint in my body ached.
No additional AE/PQC reported; Expired dose administered; This spontaneous report was received from a medical assistant and refers to a 6 months old patient of unknown gender. There was no information about the patient's concurrent conditions, allergies, drug reactions, concomitant therapies or medical history provided. On 20-JAN-2022, the patient was vaccinated with expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot # U007860, expiration date: 14-JAN-2022) (exact dose, dose number, route of administration and anatomical location were not reported) for prophylaxis. No additional adverse events occurred. The outcome of expired dose administered was not reported.
A few days after the vaccination I got a sporatic nose bleed which was stopped by applying pressure.  A few hours later it happened again but this time because it happened twice within a few hours I reached out to the EH and advised the NP I experienced it and was advised to report if via VSafe.  It was handled by applying pressure and it finally stopped.
I had typical symptoms starting approximately 24 hours after the shot.  But 6 days after the shot I had a delayed allergic reaction.  I had hives that over the course of 3-4 days covered my entire body as they rose and subsided in different areas.  I do have one picture of an arm shortly after they started spreading.  This was much worse than in shot 1, where I had a single welt on my arm show up about a week later.
Rash on chest and arm, difficult breathing and tongue swollen. Patient used Epipen at the restaurant where she visit on 06/21/2015 PM.
09/03/21; extremely sore arm; limited rom due to pain; extreme fatigue and weakness; extreme body aches and joint pain; 99.8F temp; chills. This vaccine was mandated after testing positive for high antibodies on 8/23/21 after previous Covid infection in July 2020. I fear second dose will be even worse.
This prospective pregnancy case was reported by a consumer and described the occurrence of sore arm (injection site) in a 30-year-old female subject who was vaccinated with FLULAVAL (GlaxoSmithKline) during pregnancy. A physician or other health care professional has not verified this report. The current pregnancy was by normal conception and the subject was not using contraception. There was no evidence of a defect on prenatal testing. There was no maternal or paternal history which may have an impact on the outcome of the pregnancy. The subject had no concomitant medications. On 11 September 2013 the subject received a dose of FLULAVAL (unknown, left arm) and experienced vaccine exposure during the second trimester of pregnancy. The gestational age was calculated as 22 5/7 weeks at the time of vaccination. The date of last menstrual period was 05 April 2013 and the estimated delivery date was 10 January 2014. On 11 September 2013, less than one day after vaccination with FLULAVAL, the subject experienced sore arm (injection site). At the time of reporting the event was resolved. The subject considered the event related to the vaccination. At the time of the report, the pregnancy was ongoing.
Chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHILLS (non-serious), outcome "unknown", described as "Chills ".  Additional information: This consumer reported for her sister. The patient was healthy, had the chills.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
3 days after chest discomfort and fatigue took nonsteroidal anitinflammatory, rested , avoided physical exertion for some time afterwards
Insomnia for 3 nights; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA 6780) via an unspecified route of administration in the left arm on 15Jul2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patients' medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8727) via an unspecified route of administration on 18Jun2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 18Jul2021, the patient experienced insomnia for 3 nights. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event insomnia for 3 nights resolving at the time of this report.
a runny nose hours after receiving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (a runny nose hours after receiving the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jun-2021, the patient experienced RHINORRHOEA (a runny nose hours after receiving the vaccine). At the time of the report, RHINORRHOEA (a runny nose hours after receiving the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
inappropriate schedule of vaccine administered (Dose 1: 01Feb2021, Dose 2: 10Feb2021); inappropriate schedule of vaccine administered (Dose 1: 01Feb2021, Dose 2: 10Feb2021); Fever; chills; nausea; Dry-heaves; fatigue; This is a spontaneous report from a contactable consumer reporting for himself. A 69-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number El9269/expiration date: not provided), via an unspecified route of administration, on 10Feb2021 at 01:30 (at the age of 69 years old) as a single dose in the left arm for COVID-19 IMMUNIZATION. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: not provided), via an unspecified route of administration, on 01Feb2021 at 01:00 (at the age of 69 years old) as a single dose in the right arm for COVID-19 IMMUNIZATION. Relevant medical history included lupus, hypertension, hypothyroidism. The had known allergies to peneciilin, sulfa, and doxycycline. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included ramipril, hydroxychloroquine sulfate (PLAQUENIL) and amlodipine.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On Feb2021 (also reported as "09Feb2021 at 01:30" CLARIFICATION PENDING), the patient experienced fever, chills, nausea, dry-heaves, and fatigue. The patient did not receive any treatment for these events. The outcome of the events fever, chills, nausea, dry-heaves, and fatigue was recovered on an unspecified date in Feb2021. Since the vaccination, the patient had not been tested for COVID-19.
dizziness; feeling nauseos; This case was reported by a other health professional and described the occurrence of dizziness in a female patient who received HAV (Havrix) (batch number 299X2, expiry date unknown) for prophylaxis.   On an unknown date, the patient received Havrix. On an unknown date, less than 6 months after receiving Havrix, the patient experienced dizziness and nausea. On an unknown date, the outcome of the dizziness and nausea were unknown.   It was unknown if the reporter considered the dizziness and nausea to be related to Havrix.  Additional details were provided as follows: The age at vaccination was not reported. After vaccination with dose of Havrix, the patient experienced dizziness and nausea. This accident occurred under circumstances for which super markets. The reporter requested that, GlaxoSmithKline (GSK) report this promptly to the insurer or arrange for proper investigation and disposition. Also requested that, GSK acknowledge receipt of this notice in writing within fifteen (15) days and advise the undersigned of the name and address of the insurer or other person to whom they might look for handling. This case has been linked with case US2019AMR172635, reported by the same reporter.
Inappropriate duplicate COVID vaccine administered. We were not aware that the patient had already received both Pfizer COVID shots beforehand. Patient had stated they never received the COVID shot and was not aware. No adverse effects was reported.
C/o not able to lift right arm above shoulder area last 5 days. Injection site did not show: inflammation, discharge, bruising, per pt.
My arm was sore (inj site); This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (My arm was sore (inj site)) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced VACCINATION SITE PAIN (My arm was sore (inj site)). At the time of the report, VACCINATION SITE PAIN (My arm was sore (inj site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Treatment medication was not reported.
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient's healthcare provider recommended, and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2012, a physician administered ZOSTAVAX, (lot # and route unknown) to the patient. The patient was inoculated with the ZOSTAVAX vaccine to obtain permanent prevention and protection against shingles and zoster-related injuries. In 2012, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. The patient used the ZOSTAVAX vaccine for the permanent prevention of shingles and zoster-related injuries. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. Additional information has been requested.
Narrative: Patient rec'd vaccine in February 2021 6/30/2021: HPI: 91 yo M with IDDM, HTN, CKD, anemia, low back pain, BPH, h/o sinusitis, inguinal hernia, cataracts, h/o hyperkalemia, hyperlipidemia, OA, hearing loss, hallucinations, and other chronic health conditions as below. Patient seen today for a post hospital visit. Patient suffered a fall on June 14th. He was hospitalized with pneumonia and five broken ribs. He was discharged to a rehabilitation unit. His blood sugar was elevated and he went back to hospital. Patient was discharged home on June 26th with hospice. Patient's condition continues to decline. He is alert and oriented to self. He is able to make his needs known. He is completely dependent on caregivers for his care. He is bedbound. Oxygen at 5L/m via nasal cannula continuously. Appetite is very poor. Indwelling catheter in place with moderate amount of yellow urine in drainage bag. Bowels remain regular. Skin is pale. All medication have been discontinued. He was started on lorazepam and hydrocodone in the hospital. Patient states he is comfortable. He denies pain or falls. Caregiver's goal is to keep him comfortable.
I had the flu shot given on 9/10/2019. I still have moderate arm pain with limited range of motion as of today, 9/22/2019. I contacted my physician who said I need to take Advil for two weeks, do physical therapy, and have possible steroid injections done.
4 1/2 hr p/vax pt awoke p/nap crying an unconsolable weak cry & turned white & weak (not floppy) & trembling;lips pink, sl more pale than usual;mom described pt so white could count all blood vessels on torso usually cannot;Gave TYLENOL, warm bath, color and cry became more normal. Reaction lated 1 hour.
calling for temperature evaluation for VARIVAX and notifed it was administered to multiple patients; This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. On 17-JUN-2020, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX)(strength, dosing schedule, lot#, expiration date and route of administration were not provided) for prophylaxis. Administered dose of vaccine was exposed to the temperature from -14 Celsius degrees to -10 Celsius degrees for 4 hours 15 minutes. There was a previous temperature excursion noted: from -9 Celsius degrees to 8 Celsius degrees for 2 hours 21 minutes, as recorded by a digital data logger.  This is one of multiple reports from the same reporter.; Sender's Comments:  US-009507513-2007USA003458: US-009507513-2007USA004416:
Mom; reports a significant rash around 2 weeks after vaccination administered. Doctor suggested that pt not receive any more MMR vaccines.
I slowly started developing body aches the evening of 01/26/21.  Later that evening my balance felt a little off if I turn my head or body too quickly.  I got up in the morning of 01/27/21 to get ready for work and feel light headed if I turn my head or try to walk normally and when I started to get into my car. I didn?t feel it was safe to drive so I didn?t.  Still having body aches this morning as well. But the light headedness is new. I didn?t feel that with the first vaccine dose.
74 y.o. male presented to the ER with complaints of right elbow pain and swelling.  The nursing home did call the office yesterday requesting for x-ray of the right elbow.  Bed x-ray did show an impression of:  Unremarkable limited view left elbow without evidence definite fracture or dislocation this was read by the radiologist.  Patient did have CT scan right elbow today showed an impression of:  Diffuse soft tissue edema prominence subcutaneous soft tissue gas along the dorsum forearm proximally, in no acute pathology or CT evidence of acute osteomyelitis, no vascular pathology.  It is noted that patient has swelling, redness pain, and erythema to the right elbow.  Upon examination the patient does grimace pain movement of the right level.  Patient does have a large pocket of fluid noted to the right medial epicondyle region and to the medial right upper forearm.  Skin is hot to touch, but patient's pulses were noted at 2+ 2+, and CMS is less than 3 sec. Patient did also have lab work a white blood count noted of 5 point, hemoglobin is 10.4, hematocrit was 31, platelet count is 201.  BMP showed a nonfasting glucose of 107, sodium was 135, calcium 8 1, and his GFR is 84.  Patient's sed rate is elevated at 45.  Patient's lactic acid noted at 0 4.  Patient did also have blood culture in the emergency room and that result is pending.  Patient's procalcitonin level is noted at less than 0.00.  The patient was started on vancomycin 1 g IV piggyback every 12 hr.  Patient was admitted to medical inpatient as it deemed that he will need longer than a 2 midnight stay for monitoring and IV piggyback antibiotics.
LEFT DELTOID AREA SIGNIFICANTLY SWOLLEN AND WARM TO THE TOUCH AND PAINFUL
Covid-19 treatment; Covid-19 treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult male patient received BNT162b2 (BNT162B2), on 15Mar2021 as dose 1, single (Lot number: EN6202), in left arm, on 08Apr2021 as dose 2, single (Lot number: ER8737), in left arm, on 24Nov2021 as dose 3 (booster), single (Lot number: FF3590), in left arm and on 13Jun2022 as dose 4 (booster), single (Lot number: FL3198), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Diabetes type 2" (unspecified if ongoing). Concomitant medication(s) included: GLUCOPHAGE, start date: 01Oct2018; LIPITOR, start date: 01Oct2019, stop date: 11Aug2022. The following information was reported: VACCINATION FAILURE (medically significant) with onset 02Sep2022 at 10:00, outcome "unknown", COVID-19 (medically significant) with onset 02Sep2022 at 10:00, outcome "recovering" and all described as "Covid-19 treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (02Sep2022) Positive, notes: Rebound positive test for Covid today. Therapeutic measures were taken as a result of vaccination failure, covid-19.
started feeling a really strong pain on my left thigh; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 40 year-old male patient received bnt162b2 (BNT162B2), administration date 22Mar2021 (Batch/Lot number: unknown) at the age of 40 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 22Mar2021, outcome "unknown", described as "started feeling a really strong pain on my left thigh". Additional information: The patient was walking around and started to feel a really strong pain on left thigh. The patient reported that his arm does not hurt but it feels like the injection was on the thigh.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Low grade fever 99.9-100.4, body aches, muscle aches, sore right arm, tiredness, sleepiness, headache
Headache, Myalgia, fatigue,golfball size reddness at injection site
pt c/o dizziness 1min p/vax;placed supine pt became diaphoretic & c/o cough;VS stable-no BP/heart rate change;tx w/DPH;rested/monitor x90min then sent home;no epi needed;
Sx onset 1 hr after shot - achy (muscles > joints). Temp 101.8 that eve, chills, pain in LB.
Patient got the Pfizer vaccine and fainted upon standing up. He was caught by his mother who was with him. He quickly became alert and we sat him in a chair, elevated the feet, and got a fan. Patient stated he felt as if he was going to vomit which began quickly after his statement. Patient BP and breathing was normal. Patient did want to go to the hospital to be checked which he did.
Employee presents for CoVid Vaccine Booster today She has EpiPen in hand. She reports after her 1st  CoVid vaccine she experienced "an itchy throat, but nothing after the 2nd vaccine." Employee was not sure if her symptoms were related to her vaccine.  Screened and found to be eligible for administration f CoV vaccine. Out of an abundance of caution determination was made for 30  minute post vaccine watch by RN staff, segregated from main post vaccine wait period.  Employee has checked at1340, she reports feeling mild itching of her arms, but no other side effects. Visual inspection of arms did not reveal any hives. No difficulty of breathing noted at this time.  1345 employee now experiencing increased generalized itching and an "itchy throat" 25 mg Benadryl was administered,  When mask was removed RN noted some swelling to the employee's upper lip  Determination was made to transport the employee by RN to ED. During transport employee began to make tongue smacking sounds in an effort to decrease the itchiness in her mouth. Desat O2 from 100-91%  Rapid Response Team was called.  The employee was transported to ED.